Bacteria ‘pills’ could detect gut diseases — without the endoscope
2025-11-19
(Press-News.org) Move over, colonoscopies — researchers report in ACS Sensors that they’ve developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal disease. Taken orally, the miniature “pills” also contain magnetic particles that make them easy to collect from stool. Once excreted from mouse models with colitis, the bacterial sensor detected gastrointestinal bleeding within minutes. The researchers say the bacteria in the sensor could be adapted to detect other gut diseases.
“This technology provides a new paradigm for rapid and non-invasive detection of gastrointestinal diseases,” says Ying Zhou, a co-author of the study.
In the U.S., millions of people have colorectal cancer or inflammatory bowel disease, including colitis, which can cause intestinal bleeding, diarrhea and cramping. The gold-standard diagnostic is a colonoscopy using an endoscope, a device with a camera at the end of a long cord that is threaded into the large intestine. Despite its clinical value, many people avoid the procedure because of the preparation involved and its invasiveness. Zhou, Bang-Ce Ye, Zhen-Ping Zou and colleagues are developing gentler methods using bacteria that sense disease biomarkers, such as the red blood cell component heme — a sign of intestinal bleeding.
Previously, the researchers developed heme-sensing bacteria that light up in the presence of blood, but the bacterial sensors break down in the digestive system and are hard to collect. In this current study, they encapsulated their heme-detecting bacteria and magnetic particles inside globs of sodium alginate, a thickening agent used in foods. The process creates tiny hydrogel microsphere sensors that can easily be removed from feces with a magnet after they travel through the body. Initial tests showed that the hydrogel protected the bacteria from simulated digestive fluids but also allowed heme to interact with the bacterial sensor, causing it to glow.
Then, the team administered the microspheres orally to mouse models of colitis, representing disease levels from no activity to severe stages. After the microspheres traveled through the animals’ gastrointestinal systems, the researchers retrieved the sensors from feces with a magnet and found:
Microsphere cleanup and signal analysis took about 25 minutes.
As the disease stage progressed, the intensity of the light produced by the sensor increased, which indicated more heme from mouse models with more advanced colitis.
Assessments of healthy mice given the sensor indicated the microspheres were biocompatible and safe.
Although the sensor still needs to be tested in humans, the researchers say that this method of encapsulating bacterial sensors could diagnose gastrointestinal diseases and monitor treatments and disease progression.
The authors acknowledge funding from the National Natural Science Foundation of China, the National Key Research and Development Program of China, and the China Postdoctoral Science Foundation.
The paper’s abstract will be available on Nov. 19 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acssensors.5c01813
###
The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.
Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.
Follow us: Facebook | LinkedIn | Instagram
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-19
Jennifer Munson, a cancer researcher at Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded two new National Institutes of Health grants to advance greater understanding and improved treatment of a deadly brain cancer.
While the grants from the National Cancer Institute fund different projects, both involve identifying how the movement of fluid surrounding tumor cells contributes to the spread of glioblastoma, a deadly brain tumor, into neighboring brain areas, allowing the cancer to return after surgery or radiation.
Munson and her team are identifying how liquid called interstitial fluid moves between ...
2025-11-19
While many global road maps exist, few include detailed surface information or keep pace with rapid infrastructure change. The new HeiGIT dataset closes this gap by combining 3–4 meter resolution PlanetScope imagery (2020–2024) with deep-learning models to analyze 9.2 million kilometers of major transport routes connecting cities and rural regions. The result is a high-accuracy global classification (89.2%), outperforming widely used open datasets by over 20 percentage points.
A central component of the dataset is the Humanitarian Passability Score — an index that combines surface type and ...
2025-11-19
Middle-aged Australians are keeping the country running - but it’s taking a hefty toll on their wellbeing, a new report shows.
‘A Balancing Act: Life, work and connection in the middle years’, the latest report by the Bankwest Curtin Economics Centre, finds Australians aged 35 to 55 are facing mounting pressures as they balance work, family and financial demands, with life satisfaction dipping to its lowest point in midlife.
Report lead and co-author Dr Daniel Kiely from the Bankwest Curtin Economics Centre, said while people ...
2025-11-19
Why do the world’s most prestigious firms—such as McKinsey, Goldman Sachs and other elite consulting giants, investment banks, and law practices—hire the brightest talents, train them intensively, and then, after a few years, send many of them packing? A recent study in the American Economic Review concludes that so-called adverse selection is not a flaw but rather a sign that the system is working precisely as intended.
Two financial economists, from the University of Rochester and the University of Wisconsin–Madison respectively, created a model that explains how reputation, information, ...
2025-11-19
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss and behavioral disturbances that severely impair quality of life. Despite decades of research, effective disease-modifying therapies remain elusive, underscoring the urgent need for novel neuroprotective strategies. Lithium (LIT), a well-known mood stabilizer for the treatment of bipolar disorder, shows neuroprotective effects, including inhibition of glycogen synthase kinase 3 beta, ...
2025-11-19
Wiley, a global leader in authoritative content and research intelligence, today announced the release of additional data to its IR, Raman, LC-MS, and SmartSpectra libraries, significantly broadening compound coverage. The expansion brings Wiley's spectral database offerings to over 9.5 million high-quality spectra, delivering researchers enhanced capabilities for faster, more confident compound identification.
"These updates deliver what researchers need ...
2025-11-19
COPENHAGEN (November 19, 2025)—New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
The NC-009 trial (a pan-Phase 2 clinical trial) showed that, overall, sorfequiline had greater activity than bedaquiline. The 100 mg SPaL regimen had greater activity against TB than the standard of care HRZE (isoniazid, rifampin, pyrazinamide, and ethambutol), indicating the potential ...
2025-11-19
Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications. Now, researchers at University of California San Diego and their colleagues have developed a new method to combat antibiotic-resistant bacteria using bacteriophages, or phages, for short — viruses that infect and kill bacteria — as an alternative to traditional antibiotics.
The researchers targeted Klebsiella pneumoniae, a species of bacteria notorious for its ability to resist multiple antibiotics. The dangerous pathogen can cause severe infections in hospital settings, including pneumonia and ...
2025-11-19
Researchers at the Hebrew University of Jerusalem discovered that the magnetic component of light plays a direct role in the Faraday Effect, overturning a 180-year-old assumption that only its electric field mattered. Their findings show that light can magnetically influence matter, not just illuminate it. The discovery opens new possibilities in optics, spintronics, and quantum technologies.
Researchers from the Hebrew University of Jerusalem have discovered that the magnetic component of light, not ...
2025-11-19
An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are diagnosed.
Researchers have created a system called CytoDiffusion that uses generative AI – the same type of technology behind image generators such as DALL-E – to study the shape and structure of blood cells.
Unlike many AI models, which are trained to simply recognise patterns, the researchers – ...
LAST 30 PRESS RELEASES:
[Press-News.org] Bacteria ‘pills’ could detect gut diseases — without the endoscope
